Biostar Pharmaceuticals, Inc.
BSPM · OTC
12/31/2016 | 12/31/2015 | 12/31/2014 | 12/31/2013 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -91.2% | -55.8% | 16.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 38.4% | 40.9% | 49.3% | 48.7% |
| EBITDA | -$0 | -$0 | $0 | $0 |
| % Margin | -71.2% | -78.1% | 7.8% | 11% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -239% | -92.6% | 7.9% | 1.5% |
| EPS Diluted | -2.5 | -11.36 | 2.3 | 0.49 |
| % Growth | 78% | -593.9% | 369.4% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |